Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial
2019; Springer Science+Business Media; Volume: 270; Issue: 6 Linguagem: Inglês
10.1007/s00406-019-01079-w
ISSN1433-8491
AutoresElena Huerta‐Ramos, Javier Labad, Jesús Cobo, Christian Núñez, Marta Creus, Gemma García–Parés, Daniel Cuadras, José G. Franco, Eva Miquel, Julio-César Reyes, Silvia Marcó-García, Carolina Rodríguez, Isabel Beneitez, Joan Costa‐Font, L. Silvia Castro, S. Teba, Laura Milian, Alexandrina Foix, S. Benítez Rivero, Marian Cavero, María Argemí, Fernando Teba, Belén Arranz, E. Rubio, Marta Coromina, Ángeles Santos, José Luis Bogas, Ana Taboada Barber, C. Romans, Manel Márquez, Anna Sabata, Lourdes López Nieto, Eva Willikens, Enrich Blanch, Siddharta Acebillo, Ramón Coronas, Laura Ortega, I Coll, Joaquín Valero, Jesús Rodríguez, Modesto Pérez, Inés Niubó, Montse Tost, Mari Pau Monfort, Lourdes Martorell, Elisabet Vilella, Judith Usall, Elena Huerta‐Ramos, Javier Labad, Jesús Cobo, Christian Núñez, Marta Creus, Gemma García–Parés, Daniel Cuadras, José G. Franco, Eva Miquel, Julio-César Reyes, Mercedes Roca, Judith Usall,
Tópico(s)Menopause: Health Impacts and Treatments
Referência(s)